REG - MJ Gleeson Plc - Result of AGM

MJ GLEESONAnnouncement

Today 15:00

For best results when printing this announcement, please click on link below:
https://newsfile.refinitiv.com/getnewsfile/v1/story?guid=urn:newsml:reuters.com:20251114:nRSN6575Ha&default-theme=true

RNS Number : 6575H  MJ Gleeson PLC  14 November 2025

MJ GLEESON plc

Incorporated in England and Wales

Registration number: 09268016

LEI: 21380064K7N2W7FD6434

ISIN: GB00BRKD9Z53

 

 

MJ Gleeson plc

("the Company")

 

 

MJ Gleeson plc - Annual General Meeting Results

 

The Company held its Annual General Meeting at 11:30am on Friday 14(th)
November 2025 at Grocers' Hall, Princes Street, London EC2R 8AD (the "AGM").

 

All resolutions put to the meeting were voted on by way of a poll and were
passed by the shareholders.  The following table gives results of the poll
vote:

 

                                                                                             Votes For *                       Votes Against                     Votes Withheld  Total Votes Cast
             Resolution                                                                      No. of shares  % of shares voted  No. of shares  % of shares voted  No. of shares   No. of shares  % of issued share capital
 1.          To receive and adopt the Directors' Report, the Strategic Report and the        41,115,810     99.99              4,290          0.01               18,488          41,120,100     70.38%
             financial statements together with the Independent Auditors' Report for the
             year ended 30 June 2025
 2.          To approve the Directors' Remuneration Report (excluding the Directors'         40,686,398     98.95              429,887        1.05               22,303          41,116,285     70.37%
             Remuneration Policy).
 3.          To approve the Directors' Remuneration Policy.                                  41,081,822     99.92              33,455         0.08               23,311          41,115,277     70.37%
 4.          To approve final dividend of 7p per ordinary share                              41,118,742     100.00             1,750          0.00               18,096          41,120,492     70.38%
 5.          To reappoint Fiona Goldsmith as a Director                                      35,467,056     99.02              351,183        0.98               5,320,349       35,818,239     61.30%
 6.          To reappoint Christopher Mills as a Director                                    33,113,647     92.45              2,705,401      7.55               5,319,540       35,819,048     61.30%
 7.          To reappoint Elaine Bailey as a Director                                        40,905,799     99.50              205,810        0.50               26,979          41,111,609     70.36%
 8.          To reappoint Nicola Bruce as a Director                                         40,905,799     99.50              205,810        0.50               26,979          41,111,609     70.36%
 9.          To appoint Graham Prothero as a Director                                        41,099,074     99.97              13,344         0.03               26,170          41,112,418     70.36%
 10.         To reappoint Stefan Allanson as a Director                                      41,089,993     99.94              23,925         0.06               24,670          41,113,918     70.37%
 11.         To re-appoint PricewaterhouseCoopers LLP as Independent Auditors                41,101,735     99.96              16,854         0.04               19,999          41,118,589     70.37%
 12.         To authorise the Directors to determine the Independent Auditors' remuneration  41,108,030     99.98              6,462          0.02               24,096          41,114,492     70.37%
 13.         To approve the Trust Deed and Rules of the MJ Gleeson Group Share Purchase      41,104,800     99.98              8,888          0.02               24,900          41,113,688     70.37%
             Plan
 14.         To authorise the Directors to allot shares in the Company pursuant to Section   41,093,067     99.95              20,539         0.05               24,982          41,113,606     70.37%
             551 of the Companies Act 2006
 15.         To disapply pre-emption rights in connection with a rights issue                41,094,134     99.94              23,972         0.06               20,482          41,118,106     70.37%
 16.         To disapply pre-emption rights in connection with allotment of equity           41,094,134     99.94              23,972         0.06               20,482          41,118,106     70.37%
             securities or sale of treasury shares
 17.         To authorise the Company to purchase its own shares under Section 701 of the    41,105,740     99.98              7,866          0.02               24,982          41,113,606     70.37%
             Companies Act 2006
 18.         To authorise the Company to call General Meetings other than Annual General     41,097,324     99.96              17,864         0.04               23,400          41,115,188     70.37%
             Meetings on not less than 14 clear days' notice

 

* Includes discretionary votes

 

Notes:

 

(1)  A "vote withheld" is not a vote in law and is not counted in the total
number of votes cast for or against a resolution.

 

(2)  Resolutions 1-14 were ordinary resolutions and resolutions 15-18 were
special resolutions.

 

Copies of the special business resolutions passed at the Annual General
Meeting will shortly be available for inspection via the Financial Services
Authority's National Storage Mechanism in accordance with 9.6.2(R) of the
Listing Rules.

 

There were 58,428,126 ordinary shares of 2p each in issue on 14(th) November
2025.

 

Further information is available from:

 

 MJ Gleeson plc
 Leanne Johnson

 Company Secretary

Tel: 01142 612900

14 November 2025

 

END

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact
rns@lseg.com (mailto:rns@lseg.com)
 or visit
www.rns.com (http://www.rns.com/)
.

RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our
Privacy Policy (https://www.lseg.com/privacy-and-cookie-policy)
.   END  RAGDZMMMDDZGKZM



            Copyright 2019 Regulatory News Service, all rights reserved